|
|
by Dr. Mercola
'When deciding whether or not to vaccinate, it's important to consider the risks versus the benefits. Case in point, new advice from the Joint Committee on Vaccination and Immunisation (JCVI) in the UK has determined that routine vaccination of people over 65 with the pneumococcal vaccine should be discontinued.
The Committee stated:
"JCVI has concluded that the protection the vaccine provides is poor and is not long-lasting in older people. In addition, the programme has had no discernable impact on the incidence of invasive pneumococcal disease in older people. The committee has advised, therefore, that there is little benefit to continuing the programme and that it should be stopped."
Millions of people over 65 have already received the pneumonia vaccine, which was often offered alongside the flu vaccine in the UK -- and the Department of Health was reportedly still promoting it as recently as January.
For a vaccine that has provided "poor" protection against illness, the stakes have been high. Mail Online reported official figures from the Medicines and Healthcare products Regulatory Agency that stated the vaccine, sold under brand names Pneumovax and Pneumovax II, has been linked to 30 deaths and more than 3,300 reported side effects.'
Read more...
Iam
Raju Al Nima
From
healtheverydays
Find out health informations update, beauty care,fitness energizing moves, easy recipes, expert tips, and advice on losing weight from healtheverydays
Find out health informations update, beauty care,fitness energizing moves, easy recipes, expert tips, and advice on losing weight from healtheverydays
Posting Komentar